Browsing by Subject "Omalizumab"
Now showing items 1-3 of 3
(Karger, 2016)Background: Current guidelines on chronic spontaneous urticaria (CSU) suggest a treatment based on a 3-step approach that aims at total symptom control, starting with H1 antihistamines. However, a significant number of ...
(Current Medicine Group, 2018)Purpose of Review Since omalizumab has been approved for urticaria, numerous randomized and real-life observational trials have been published. We reviewed the period January 2017 February 2018. Recent Findings Omalizumab ...